- Tadalafil can improve erectile function when appropriately prescribed after medical assessment
- Tadalafil is an oral PDE5 inhibitor used to improve erections in men with erectile dysfunction (ED)
- Repeated difficulty getting or keeping an erection can affect intimacy & may signal an underlying health problem
- ED can be caused by blood-vessel, metabolic, hormonal, neurological, medication-related or psychological factors
- Persistent ED deserves a proper clinical evaluation rather than self-medicating with unverified sexual-enhancement products
Relation Between Tadalafil and ED
Tadalafil for erectile dysfunction (ED) refers to the use of tadalafil, an oral phosphodiesterase type 5 (PDE5) inhibitor, to help a man achieve and maintain an erection sufficient for satisfactory sexual activity.
ED is not simply "weakness" or a normal consequence of getting older. The Malaysian Ministry of Health defines ED as a persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance.
It can have organic, psychogenic or mixed causes, with mixed causes being common in clinical practice.
Tadalafil does not directly create sexual desire and does not cause an erection without sexual stimulation. Its role is to improve the physiological response to sexual stimulation by increasing the availability of a signalling molecule called cyclic guanosine monophosphate (cGMP) in penile tissue.
In the current Malaysian clinical framework, PDE5 inhibitors are among the established pharmacological treatments for ED. The 2024 Malaysian Clinical Practice Guideline (CPG) on ED was developed by the Ministry of Health Malaysia together with the Malaysian Urological Association, Malaysian Family Medicine Specialists' Association and Academy of Medicine Malaysia.
How common is ED in Malaysia?
ED is more common than many men realise.
The National Health and Morbidity Survey (NHMS) 2019 estimated probable moderate-to-severe ED in 31.6% of sexually active Malaysian men aged 18 years and above, while probable mild ED affected another 47.1%.
More recent Malaysian research published in Sexual Medicine in 2026 found that 32.7% of healthy, sexually active men aged 18–39 years in the study had some degree of ED, including 3.9% with severe ED. This is important because ED is not limited to older men.
The figures come from different study populations and methods, so they should not be interpreted as meaning every Malaysian man has ED. They do, however, reinforce an important clinical message: ED is a genuine men's health issue in Malaysia, including among younger adults.
Read : Erectile Dysfunction in Young Men Based On Data (Malaysia)
Why Does Erectile Dysfunction Happen?
Tadalafil treats the erectile problem, but a doctor should still consider why the ED is happening. The Malaysian CPG and EAU guidelines describe ED as multifactorial. Important causes and contributors include:
1. Vascular causes
An erection depends on adequate arterial blood flow and healthy endothelial function. Conditions such as:
- high blood pressure
- coronary artery disease
- diabetes
- dyslipidaemia
- obesity
- metabolic syndrome
- smoking
- physical inactivity
can impair penile blood flow and erectile rigidity.
2. Diabetes
Diabetes can affect both the blood vessels and nerves involved in erection. Poor glycaemic control may therefore contribute to progressive erectile difficulty. ED and diabetes frequently coexist clinically.
3. Hormonal factors
Low testosterone or other endocrine disorders can contribute, particularly when ED occurs together with:
- reduced sexual desire
- fatigue
- reduced energy
- reduced muscle mass or other features suggestive of hypogonadism.
Not every man with ED has testosterone deficiency, which is why hormonal evaluation should be based on clinical assessment rather than assuming low testosterone is the cause.
4. Neurological causes
Nerve disorders, spinal cord conditions, stroke, diabetes-related neuropathy and some neurological diseases can interfere with the signals required for erection.
5. Medication-related ED
Some medicines can contribute to erectile difficulties, including certain antihypertensives, antidepressants, antipsychotics and antiandrogenic drugs. A medication review is therefore an important part of the assessment.
6. Psychological & relationship factors
Stress, anxiety, depression, performance anxiety, relationship difficulties and negative expectations about sexual performance can contribute to ED.
Psychological factors do not mean that the symptoms are "imaginary". The erection process involves the brain, nerves, hormones and blood vessels, so psychological distress can genuinely affect erectile function.
7. Lifestyle factors
Smoking, excessive alcohol intake, obesity and physical inactivity can worsen erectile function. Lifestyle modification is therefore not an optional add-on; it forms part of evidence-based ED management.
Read : How Erectile Dysfunction Therapy Treat Your Penile in Weeks
Symptoms of Erectile Dysfunction
ED usually presents as a pattern of inadequate erectile function, rather than one isolated bad sexual experience. Common symptoms include:
- losing the erection before or during intercourse
- an erection that is not firm enough for penetration
- persistent dissatisfaction with sexual performance
- difficulty getting an erection despite sexual stimulation
- needing considerably more stimulation to maintain firmness
- reduced confidence because erections have become unpredictable
A doctor may also ask about:
- morning or spontaneous erections
- sexual desire
- ejaculation
- orgasm
- penile curvature or pain
- urinary symptoms
- cardiovascular symptoms
- stress, anxiety and relationship factors.
A validated questionnaire such as the International Index of Erectile Function (IIEF) or the Erectile Hardness Score (EHS) can help quantify severity and monitor treatment response.
How Tadalafil Works: A Clinical Deep Dive
A normal erection begins partly with sexual stimulation, which triggers release of nitric oxide (NO) in penile tissue.
NO activates an enzyme called guanylate cyclase, which increases cGMP. Rising cGMP relaxes smooth muscle in the corpus cavernosum, allowing increased arterial inflow and expansion of the erectile tissue.
The enzyme PDE5 normally breaks down cGMP. Tadalafil selectively inhibits PDE5. This means cGMP remains active for longer, helping penile smooth muscle stay relaxed and supporting blood flow during sexual stimulation. This distinction is important:
"Tadalafil supports the natural erectile response; it does not replace sexual stimulation."
Tadalafil has a relatively long pharmacokinetic half-life of approximately 17.5 hours, which contributes to its prolonged clinical window.
Typical tadalafil regimens for ED
The Malaysian CPG and EAU guidance describe two broad approaches:
| Regimen | Typical clinical approach |
|---|---|
| As-needed tadalafil | Usually started at 10 mg, taken at least about 30 minutes before sexual activity; may be adjusted according to efficacy and adverse effects |
| Daily tadalafil | 5 mg once daily is a commonly used regimen when frequent or more spontaneous sexual activity is preferred |
The EAU guideline describes an effectiveness window beginning around 30 minutes after administration, with peak efficacy at approximately 2 hours, and clinical effectiveness lasting up to 36 hours.
A 20 mg tablet is therefore not automatically the correct starting dose for every man. Dose selection should be individualised according to response, tolerability, other medicines, cardiovascular status and kidney or liver function.
Key Benefits of Tadalafil for ED
1. Long erectile-response window
The best-known practical advantage of tadalafil is its long duration. Its clinical window can extend up to 36 hours, which may reduce the feeling that sexual activity has to occur at a very specific time immediately after taking a tablet.
This does not mean a continuous erection for 36 hours. It means the medicine can continue to facilitate an erection when sexual stimulation occurs during that period.
2. Proven improvement in erectile function
In a 12-week dose-response study cited by the EAU, improved erections were reported by 67% of men taking 10 mg tadalafil and 81% taking 20 mg, compared with 35% with placebo.
These figures describe study populations and should not be interpreted as a guarantee that an individual patient will respond in the same way.
3. Useful option for men who prefer spontaneity
Once-daily tadalafil 5 mg can be appropriate for some men who prefer not to connect medication timing directly to sexual activity.
The EAU notes that daily tadalafil provides an alternative for couples who want more spontaneous sexual activity or anticipate frequent intercourse.
4. Can be useful when ED and urinary symptoms coexist
Benign prostatic hyperplasia (BPH) is enlargement of the prostate that can produce lower urinary tract symptoms (LUTS), such as urinary frequency, urgency or a weak stream.
Tadalafil 5 mg once daily can improve erectile function and may also help certain men with concomitant LUTS/BPH.
5. Can improve sexual confidence when ED is successfully managed
ED can create an anxiety-performance cycle: a difficult sexual experience leads to worry about the next encounter, which can further interfere with erectile function.
Appropriate ED treatment may therefore have benefits beyond penile rigidity, especially when combined with education and, where indicated, psychosexual or relationship-based intervention.
Potential Side Effects of Tadalafil
Most common side effects are related to tadalafil's vasodilatory effects and are usually mild and self-limiting. Common adverse effects include:
| Side effect | Clinical context |
| Headache | Common, often transient |
| Dyspepsia / indigestion | May present as abdominal discomfort or heartburn |
| Back pain | A recognised tadalafil-associated adverse effect |
| Myalgia | Muscle discomfort |
| Nasal congestion | Related to vascular effects |
| Flushing | Facial warmth or redness |
| Dizziness | May occur because of blood-pressure effects |
The EAU guideline reports headache, dyspepsia, back pain and myalgia among the recognised adverse effects of tadalafil.
Less common but clinically important problems
A man should seek urgent medical attention for:
- an erection lasting 4 hours or longer, because this may represent priapism
- sudden loss or significant reduction of vision
- sudden hearing loss
- severe chest pain or other concerning cardiovascular symptoms.
Who should not take tadalafil without medical assessment?
The most important interaction is with organic nitrates or nitric-oxide donor medicines, because combined use can cause a potentially dangerous fall in blood pressure.
This includes medicines such as glyceryl trinitrate (GTN) and certain recreational nitrate products such as "poppers".
Tadalafil also requires careful consideration in men with significant cardiovascular disease, certain recent cardiovascular events, uncontrolled blood pressure problems, selected kidney or liver conditions, and when interacting medicines are being taken.
That is why purchasing "tadalafil" from an unverified online seller or from a sexual-enhancement product is not equivalent to receiving a medically assessed prescription.
Tadalafil and Other ED Medicines
Tadalafil belongs to the same PDE5 inhibitor class as sildenafil, but the drugs have different pharmacokinetic profiles.
| Feature | Tadalafil | Sildenafil |
| Drug class | PDE5 inhibitor | PDE5 inhibitor |
| Typical as-needed starting dose | 10 mg | 50 mg |
| Approximate onset | ~30 minutes | ~30–60 minutes |
| Clinical window | Up to 36 hours | Up to about 4–12 hours depending on source/individual response |
| Daily regimen | 5 mg commonly used | Not the usual ED daily regimen |
| Main practical advantage | Longer window / spontaneity | Often shorter timing window |
The choice is not simply "which tablet is stronger?" The appropriate medicine depends on the man's health, frequency of intercourse, previous response, adverse effects, expectations, concomitant conditions and medication interactions. The EAU specifically recommends individualising the choice of PDE5 inhibitor.
Tadalafil and ED in Malaysia Today
The Malaysian clinical picture deserves particular attention because ED is common, frequently under-discussed and often associated with chronic disease.
The 2024 Malaysian CPG on Erectile Dysfunction makes an important clinical point: ED can arise from vascular, neurogenic, hormonal, anatomical, medication-related and psychological mechanisms. Management therefore begins with assessment, not simply prescribing a tablet.
The guideline's expert review committee included Malaysian specialists such as:
Dato' Dr. Rohan Malek — Consultant Urologist & Renal Transplant Surgeon, Damansara Specialist Hospital 2, Kuala Lumpur. His inclusion as chairperson of the CPG review committee reflects the multidisciplinary approach used to assess ED management in Malaysia.
Prof. Dato' Dr. Shaiful Bahari Ismail — Professor of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia (USM), Health Campus. His academic profile specifically identifies male sexual and reproductive health as one of his areas of training and research.
Prof. Dr. Christopher Ho Chee Kong — Consultant Urologist and specialist in Urology, with academic and clinical appointments involving Taylor's University, UKM Medical Centre and specialist practice in Malaysia. He is also among the experts involved in Malaysian men's sexual-health research and education.
The broader Malaysian evidence is equally important. NHMS 2019 recorded a high prevalence of probable moderate-to-severe ED among sexually active men, while a 2026 study in Sexual Medicine found that roughly one in three healthy Malaysian men aged 18–39 years in its sample had some form of ED.
From my clinical perspective, this is why I would not treat tadalafil as simply a "sex pill". When a man presents with ED, I want to understand what changed, how consistently it is happening, whether morning erections remain, whether libido has changed, what medicines he takes, and whether there are metabolic or cardiovascular risk factors.
The objective is not only to improve tonight's erection. It is to identify the safest and most appropriate treatment plan for that particular patient.
When Should You See a Doctor?
You should arrange a clinical assessment when erectile problems are:
- recurring rather than isolated;
- occurring for several weeks or months;
- affecting intercourse or relationship satisfaction;
- accompanied by reduced libido;
- associated with diabetes, hypertension, obesity or cardiovascular disease;
- associated with urinary symptoms;
- occurring after pelvic surgery, prostate treatment or significant injury;
- associated with medication use that may affect sexual function;
- occurring together with anxiety, depression or major psychological distress.
The EAU recommends a structured assessment consisting of a medical and sexual history, physical examination and appropriate laboratory evaluation. Depending on the presentation, this can include blood pressure, BMI or waist circumference, glucose/HbA1c, lipid profile and morning testosterone.
Read : Testosterone Case Study : Patient Results & Recovery (2026)
Why should ED not simply be ignored?
ED is sometimes an early clinical clue to broader vascular or metabolic problems.
The EAU considers ED to share important risk factors with cardiovascular disease and notes that ED can provide an opportunity to identify previously unrecognised cardiovascular risk.
This is particularly relevant in a younger man. A new persistent change in erectile function should not automatically be dismissed as "stress" without asking whether there are other underlying factors.
What happens if treatment is delayed?
The consequences are not always immediate, but untreated ED can contribute to:
- worsening sexual confidence;
- avoidance of intimacy;
- relationship strain;
- increasing performance anxiety;
- missed opportunities to detect diabetes, hypertension or cardiovascular risk;
- delayed treatment of hormonal, neurological or medication-related causes.
The appropriate response is not panic. It is proper assessment followed by targeted treatment.
Practical Advice Before Taking Tadalafil
Do not self-escalate the dose
A stronger dose is not automatically a better dose. Higher doses can also increase adverse effects.
Tell your doctor about all medicines
Especially mention:
- nitrates or GTN;
- alpha-blockers;
- blood-pressure medicines;
- medications that affect CYP3A4 metabolism;
- significant kidney or liver disease;
- previous cardiovascular events.
Do not combine PDE5 inhibitors on your own
Taking tadalafil together with another ED medicine such as sildenafil without medical direction can increase the risk of adverse effects and blood-pressure problems.
Remember that sexual stimulation is still required
Tadalafil facilitates the erectile response. It does not create sexual desire or automatically produce an erection.
Buy only from legitimate healthcare channels
The safety of tadalafil depends not only on the active ingredient but also on correct dosing, patient selection, drug interactions and product authenticity.
This is especially relevant in Malaysia, where unregistered sexual-enhancement products have previously been associated with undeclared ED drugs.
Read : Why New Fathers Get ED: The Science & Solutions (Malaysian)
Conclusion
Tadalafil for ED is an evidence-based treatment, but it is not simply a stronger or longer-lasting "sex pill."
It works by inhibiting PDE5 and enhancing the natural nitric oxide-cGMP pathway involved in penile erection. Its principal practical advantage is its long clinical window, which can last up to 36 hours after an as-needed dose.
At the same time, tadalafil is not appropriate for every man. The most important safety issue is its interaction with nitrates and other nitric-oxide donor medicines, and treatment should be individualised when cardiovascular disease, kidney or liver impairment, other medicines or significant comorbidities are present.
For Malaysian men, the larger message is equally important: persistent ED should be assessed rather than hidden or self-treated indefinitely. Malaysian data show that ED is common, including among younger men, and it can coexist with metabolic, cardiovascular, hormonal and psychological health problems.
A qualified doctor can determine whether tadalafil is suitable, which regimen is appropriate, whether another treatment would be better, and whether the ED is signalling an underlying health problem that also needs attention.
References :
- Ministry of Health Malaysia, Management of Erectile Dysfunction, 28-04-2025 (official online publication of the 2024 CPG). Access: Management of Erectile Dysfunction – Ministry of Health Malaysia
- Ministry of Health Malaysia, Quick Reference for Healthcare Providers: Management of Erectile Dysfunction, 28-04-2025. Access: Quick Reference for Healthcare Providers – Management of Erectile Dysfunction
- European Association of Urology, Management of Erectile Dysfunction – EAU Guidelines on Sexual and Reproductive Health, 2026 edition. Access: EAU Guidelines – Management of Erectile Dysfunction
- American Urological Association, Erectile Dysfunction: AUA Guideline, 07-05-2018. Access: Erectile Dysfunction: AUA Guideline
- NCBI Bookshelf, Tadalafil, 20-03-2024. Access: Tadalafil – NCBI Bookshelf
- Sexual Medicine, Prevalence of erectile dysfunction among healthy and sexually active Malaysian men aged 18 to 39 years, 14-04-2026. Access: Sexual Medicine – Malaysian ED prevalence study
- Ministry of Health Malaysia, National Health and Morbidity Survey 2019: Technical Report – Volume I, 2019. Access: NHMS 2019 – National Health and Morbidity Survey
- Journal of Men's Health, Daily Dose of 5 mg Tadalafil Safely Improves Erectile Function and Liver Function Enzymes in Smokers, 31-07-2022. Access: Journal of Men's Health – Tadalafil study
- UTMB News, Study finds erectile dysfunction medications associated with significant reductions in deaths, cardiovascular disease, dementia, 19-11-2024. Access: UTMB News – Erectile dysfunction medications study
This articles is written and reviewed by :
Dr. Rakesh A/L Subbiah
Bachelor of Medicine, Bachelor of Surgery & Bachelor of Obstetrics, National University of Ireland.
Malaysia Medical Council (MMC) Full Registration No. 51375.
